North America Colorectal Cancer Market - Global Trends, Share, Size, Growth, Opportunities and Forecast to 2028

The colorectal cancer market in North America is expected to grow from US$ 8,559.27 million in 2022 to US$ 11,198.11 million by 2028; it is estimated to grow at a CAGR of 3.4% from 2022 to 2028.

Colorectal cancer is one of the most commonly found lethal cancers in individuals with the combined influence of genetic and environmental factors. A significant population in North America is diagnosed with colorectal cancer. According to the Centers for Disease Control and Prevention (CDC) and the American Cancer Society, an estimated 1.93 million adults in the US were diagnosed with colon and cancer, and 53,200 deaths were caused by colorectal cancer in 2020. These statistics showcase increased demand for advanced cancer diagnostics and therapeutics in the region. Thus, the rising prevalence of colorectal cancer and the rising number of patients diagnosed with the disease are driving the growth of the North America colorectal cancer market.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the North America colorectal cancer market at a substantial CAGR during the forecast period.

📚 Download Sample PDF Copy@ https://www.businessmarketinsights.com/sample/TIPRE00009241

North America Colorectal Cancer Strategic Insights

Strategic insights for the North America Colorectal Cancer provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

📚Full Report Link @ https://www.businessmarketinsights.com/reports/north-america-colorectal-cancer-market

North America Colorectal Cancer Market

Colorectal cancer (CRC) is one of the most commonly diagnosed cancers in North America, and it remains a significant public health concern due to its high incidence, mortality rates, and the economic burden it places on healthcare systems. The North American colorectal cancer market encompasses a wide array of diagnostic, therapeutic, and monitoring products and services aimed at the prevention, early detection, and treatment of this disease. In this article, we explore the market landscape, key drivers, challenges, and emerging trends shaping the North American colorectal cancer market.

Overview of Colorectal Cancer

Colorectal cancer refers to cancer that begins in the colon or , both parts of the large intestine. CRC is the third most commonly diagnosed cancer in both men and women in the United States, after breast and prostate cancers. It is also one of the leading causes of cancer-related deaths in the region. The disease develops when abnormal cells in the colon or grow uncontrollably, leading to the formation of tumors.

Segments Covered
By Modality

Diagnosis Type
Therapy Type
Imaging Type
By End User

Hospitals
Diagnostic and Research Laboratories
Risk factors for colorectal cancer include age (most cases occur in individuals aged 50 or older), family history of the disease, lifestyle factors such as diet, smoking, physical inactivity, and obesity, as well as conditions such as inflammatory bowel disease (IBD) and certain genetic syndromes. Early detection through regular screenings, such as colonoscopies, can help identify precancerous growths or cancers in their early stages, improving treatment outcomes.

The List of Companies

Abbott

Amgen Inc.

Bruker Corporation

Clinical Genomics Technologies Pty Ltd.

Epigenomics AG

Hoffmann-La Roche AG
Quest Diagnostics

VolitionRx Limited

North America Colorectal Cancer Market

Colorectal cancer (CRC) is one of the most commonly diagnosed cancers in North America, and it remains a significant public health concern due to its high incidence, mortality rates, and the economic burden it places on healthcare systems. The North American colorectal cancer market encompasses a wide array of diagnostic, therapeutic, and monitoring products and services aimed at the prevention, early detection, and treatment of this disease. In this article, we explore the market landscape, key drivers, challenges, and emerging trends shaping the North American colorectal cancer market.

Overview of Colorectal Cancer

Colorectal cancer refers to cancer that begins in the colon or , both parts of the large intestine. CRC is the third most commonly diagnosed cancer in both men and women in the United States, after breast and prostate cancers. It is also one of the leading causes of cancer-related deaths in the region. The disease develops when abnormal cells in the colon or grow uncontrollably, leading to the formation of tumors.

Risk factors for colorectal cancer include age (most cases occur in individuals aged 50 or older), family history of the disease, lifestyle factors such as diet, smoking, physical inactivity, and obesity, as well as conditions such as inflammatory bowel disease (IBD) and certain genetic syndromes. Early detection through regular screenings, such as colonoscopies, can help identify precancerous growths or cancers in their early stages, improving treatment outcomes.

You can see this-
Europe Synthetic Leather Market- https://www.openpr.com/news/3910026/europe-synthetic-leather-market-statistics-trends-size
Europe EV Charging Infrastructure Market- https://www.openpr.com/news/3911041/europe-ev-charging-infrastructure-market-analysis-segments

Contact US
Contact Person : Ankit Mathur
Phone : +1-646-491-9876

About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications

This release was published on openPR.